OpportunityMobile Application for part-time workforce managementGyggs is an on-demand platform for small business owners, managers and part-time workers who reside in Massachusetts and surrounding states to post and apply for job opportunities.
The platform allows small business owners from the service industry including, the hotel industry, laundry services, groceries, convenient stores, and liquor deliveries, to look for part-time workers who can work in shifts.ApproachThe mobile platform is designed as a native iOS and Android mobile application with persona and role-based design.
Those looking for opportunities can look for work opportunities by searching on the Gyggs platform.
They can create their profile; to easily apply for the job in their desired location.ImpactEasy access to find a professional through online location servicesThe mobile application can be leveraged by the business owners to publish a job opportunity or a gig to find the right professional.
Professionals can easily search for gigs posted by business owners through location services.
It is designed to bring efficiencies and improve profitability for the service industry.
You must have heard about the HL7 term if you are in the healthcare sector.
Supported by various bodies in the healthcare sector, HL7 has been implanted and accepted by more than 1600 members in more than 50 countries.
These standards are used for easy sharing and minimizing the risk factors.HL7 works on the application layer of systems following the OSI model of application designing.
ASCII code is used here.
In HL7 messages, more than 120 different segments are available.HL7 CompositesEach segment in the HL7 message will contain composites also.
These are formed by primitive data types, for example, character string or number.
Apart from cancer, it has the potential to treat other diseases caused due to genetic disorders.
Such changes are known as genetic mutations and can also be passed on to future generations.
In the case of gene therapy, new genes are introduced, or existing defective genes are replaced or inactivated within the cell.
Scientists are exploring the different aspects of the therapy, its efficiency, and the risk involved.
For the commercialization of cell and gene therapy, we need to consider regulatory guidelines, manufacturing, patient education, logistics, and more.
A shift to automated processes to reduce operator handling will reduce the risk of contamination.
Though, as per the latest statistics, the survival chances of cancer patients have increased dramatically over the years, the war is far from over.
Now it is used to treat autoimmune disease, urinary problems, repair spinal cord injuries, and improve the weakened immune system.
Researchers have been working on gene therapy for 40 years.
In the year 2017, U.S. Food and Drug Administration had approved the first gene therapy treatment – Kymriah.
We do have a long way to go to make cell and gene therapy available for people at large.Cell and gene therapy soon a reality?Personalized medicine to cure cancerAfter years of research, we have a chance to beat the relentless Cancer.
For example, a company like Novartis is all set to expand Kymriah treatment.Regulatory SupportRegulatory bodies are now open and collaborative to recognize and acknowledge the potential of cell and gene therapy treatments.
OpportunityMobile Application for part-time workforce managementGyggs is an on-demand platform for small business owners, managers and part-time workers who reside in Massachusetts and surrounding states to post and apply for job opportunities.
The platform allows small business owners from the service industry including, the hotel industry, laundry services, groceries, convenient stores, and liquor deliveries, to look for part-time workers who can work in shifts.ApproachThe mobile platform is designed as a native iOS and Android mobile application with persona and role-based design.
Those looking for opportunities can look for work opportunities by searching on the Gyggs platform.
They can create their profile; to easily apply for the job in their desired location.ImpactEasy access to find a professional through online location servicesThe mobile application can be leveraged by the business owners to publish a job opportunity or a gig to find the right professional.
Professionals can easily search for gigs posted by business owners through location services.
It is designed to bring efficiencies and improve profitability for the service industry.
Apart from cancer, it has the potential to treat other diseases caused due to genetic disorders.
Such changes are known as genetic mutations and can also be passed on to future generations.
In the case of gene therapy, new genes are introduced, or existing defective genes are replaced or inactivated within the cell.
Scientists are exploring the different aspects of the therapy, its efficiency, and the risk involved.
For the commercialization of cell and gene therapy, we need to consider regulatory guidelines, manufacturing, patient education, logistics, and more.
A shift to automated processes to reduce operator handling will reduce the risk of contamination.
You must have heard about the HL7 term if you are in the healthcare sector.
Supported by various bodies in the healthcare sector, HL7 has been implanted and accepted by more than 1600 members in more than 50 countries.
These standards are used for easy sharing and minimizing the risk factors.HL7 works on the application layer of systems following the OSI model of application designing.
ASCII code is used here.
In HL7 messages, more than 120 different segments are available.HL7 CompositesEach segment in the HL7 message will contain composites also.
These are formed by primitive data types, for example, character string or number.
Though, as per the latest statistics, the survival chances of cancer patients have increased dramatically over the years, the war is far from over.
Now it is used to treat autoimmune disease, urinary problems, repair spinal cord injuries, and improve the weakened immune system.
Researchers have been working on gene therapy for 40 years.
In the year 2017, U.S. Food and Drug Administration had approved the first gene therapy treatment – Kymriah.
We do have a long way to go to make cell and gene therapy available for people at large.Cell and gene therapy soon a reality?Personalized medicine to cure cancerAfter years of research, we have a chance to beat the relentless Cancer.
For example, a company like Novartis is all set to expand Kymriah treatment.Regulatory SupportRegulatory bodies are now open and collaborative to recognize and acknowledge the potential of cell and gene therapy treatments.